CSIMarket
 
Veradigm Inc   (MDRX)
 

Veradigm Inc's Customers Performance

MDRX



 
MDRX's Source of Revenues During the corresponding time, Veradigm Inc saw a revenue deteriorated by -3.72 % year on year, sequentially revenue grew by 2.46 %. While revenue at the Veradigm Inc 's corporate clients

List of MDRX Customers




for the same period Veradigm Inc revnue deteriorated by -3.72 % year on year, sequentially revenue grew by 2.46 %.

List of MDRX Customers

Veradigm Inc's Business Units






Veradigm Inc's Comment on Sales, Marketing and Customers



Approximately 75,000 physician practices, 3,400 hospitals and 100,000 coordinated community care organizations use our products and services. Our clients, which include some of the most prestigious medical groups and hospitals in the United States, often serve as reference sources for prospective clients that are interested in purchasing our solutions.


  News about Veradigm Inc Contracts

Evolving Cardiovascular Health: Veradigm and American College of Cardiology's TRANSFORM VAX Initiative Puts Influenza Vaccination in the Spotlight

Combating Cardiovascular Risks: Veradigm and American College of Cardiology Join Forces to Promote Influenza Vaccination EducationIn a groundbreaking move towards enhancing cardiovascular health, Veradigm Inc. and the American College of Cardiology (ACC) have teamed up to launch an innovative initiative called TRANSFORM VAX. This collaborative effort aims to foster awareness and understanding of the crucial role influenza vaccination plays in safeguarding cardiovascular well-being. Recognizing the significant link between influenza and adverse cardiovascular events, the alliance seeks to empower individuals and healthcare providers with comprehensive education and resources.Recent studies have presented comp...

Veradigm Secures Nasdaq's Vote of Confidence, Pledges to Uphold Regulatory Standards

Veradigm Secures Continued Listing on Nasdaq Capital Market, Emphasizing Commitment to Compliance
Veradigm Inc., a leading health IT company, has successfully obtained a favorable decision from the Nasdaq Hearings Panel, allowing for its continued listing on the prestigious Nasdaq Capital Market, pending compliance with specific filing requirements. The panel s decision acknowledges Veradigm s progress and establishes a clear roadmap for the company, while affirming its commitment to maintaining the highest standards of regulatory compliance.
Under Nasdaq Listing Rule 5250(c)(1), Veradigm is required to demonstrate compliance with certain filing requirements by February 27, 2024, to secure its contin...




Veradigm Inc’s Comment on Sales, Marketing and Customers


Approximately 75,000 physician practices, 3,400 hospitals and 100,000 coordinated community care organizations use our products and services. Our clients, which include some of the most prestigious medical groups and hospitals in the United States, often serve as reference sources for prospective clients that are interested in purchasing our solutions.








MDRX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Veradigm Inc 520.32 593.50 -374.26 8,900
SUBTOTAL 0.00 0.00 0.00 -

Sources: Veradigm Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Veradigm Inc’s corporate clients.
For your research, we’ve provided 9 tables on Veradigm Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.